Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs.
about
Syringe access for the prevention of blood borne infections among injection drug usersImplementation of an innovative, integrated electronic medical record (EMR) and public health information exchange for HIV/AIDSThe cost-effectiveness of the WINGS intervention: a program to prevent HIV and sexually transmitted diseases among high-risk urban women.The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individualsCosts and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testingModel-based evaluation of HIV prevention interventions.Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand.Implicit valuation of a blood-exclusion decision.When is an HIV infection prevented and when is it merely delayed?A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, CanadaStructural interventions for HIV prevention in the United States.Efavirenz: a pharmacoeconomic review of its use in HIV infection.Probabilistic cost-effectiveness analysis of HIV prevention. Comparing a Bayesian approach with traditional deterministic sensitivity analysis.Medicaid and the HIV/AIDS Epidemic in the United StatesCost savings threshold analysis of a capacity-building program for HIV prevention organizationsCost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United StatesExpanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United KingdomThe cost-effectiveness of a modestly effective HIV vaccine in the United States.The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.Sudarshan Kriya yoga improves quality of life in healthy people living with HIV (PLHIV): results from an open label randomized clinical trialThe estimated direct medical cost of sexually transmitted diseases among American youth, 2000.HIV prevention, cost-utility analysis, and race/ethnicity: methodological considerations and recommendations.Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeaeThe contribution of emotion regulation difficulties to risky sexual behavior within a sample of patients in residential substance abuse treatmentMedical costs and quality-adjusted life years associated with smoking: a systematic review.Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China.Cost-effectiveness of universal screening for chlamydia and gonorrhea in US jailsCost-effectiveness of HIV counseling and testing in US prisonsWhen "heightened" means "lessened": the case of HIV prevention resources in the United States.Economic models of antiretroviral therapy: searching for the optimal strategy.Economic Evaluation of Community-Based HIV Prevention Programs in Ontario: Evidence of Effectiveness in Reducing HIV Infections and Health Care CostsThe cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, CanadaA systematic review of cost-utility analyses in HIV/AIDS: implications for public policy.Counseling Psychology and Chronic Health Conditions: A Call for ActionPotential population health outcomes and expenditures of HIV vaccination strategies in the United StatesEcological theory to enhance infectious disease control and public health policy.Costs of HIV prevention among out-of-treatment drug-using women: results of a randomized controlled trial.Major Depression and Risky Sexual Behavior among Substance Dependent Patients: The Moderating Roles of Distress Tolerance and Gender.Cost-effectiveness of Methadone Maintenance Treatment in Prevention of HIV Among Drug Users in Shiraz, South of Iran.
P2860
Q21257250-2668AF47-4909-4B55-8BAA-B0346C028B74Q24630050-2C9F2651-BE87-491B-8E83-533CDB87807BQ24793799-6C4D3C93-A165-42ED-ABEC-F5624B6C69A1Q28205170-294B7909-6AC9-497D-84B9-DD25CDBCBABAQ28469229-BF1AFF31-A87F-422B-809A-BD15A78088C5Q33583238-639C7CAC-5BA2-4440-A15C-F05FB316C756Q33626116-F831541B-9D06-45DB-A51B-D9213E3B7059Q33860874-D0A79250-CDC8-4C2A-9B34-0BE39EDEBF04Q34007192-76D448DF-B2C4-4434-91A2-3C294D98389CQ34009387-9AA9E402-EB87-419C-AF1B-92155A337A9AQ34205603-EA7CE48A-A10F-42E1-AA74-F618A72A7577Q34268304-C491DBD3-0741-4105-AAEC-4CFD761E186BQ34323538-D01D0616-565C-450D-8669-C0AB1EC8AEA9Q34327181-3DEA840D-C97A-4A14-A6E9-3A5054B46BAFQ34906301-21B28BF1-B4C2-41F4-9C6F-5D1D6BE6A384Q35058786-1746F5B9-DE97-4A4B-9452-55A5D1849D8EQ35157015-DA6F118C-7B7D-46A8-B555-DFBD08D613B4Q35165189-C6E07B6A-3951-4598-889E-BE7FECABAC20Q35214966-4F4C29D4-3924-4400-995C-D891EF955A36Q35520373-3A482B26-8431-4E77-9909-7FCC8B67A18AQ35675023-9A35E495-F788-44A5-8EA9-EC17DB937D85Q35748117-81E87637-4B88-4918-B908-D442957D4474Q35873375-5043C13C-22A8-4A21-A620-F1275DF2E652Q36074535-7168EB1F-AA87-44B4-9C10-358BD7221156Q36086596-DE35855B-B215-4B29-9FD4-996545D7C757Q36205807-A75F1876-64BB-43CA-A77C-20E54F14C8C9Q36272418-0962CCC0-8E4F-4F00-B836-56981065C1D1Q36273908-79F129BE-43CC-4DD8-8C57-1D287D8C4143Q36440990-C20F1DF7-FAFE-4DC1-B83E-364A960DC208Q36520576-73B6C245-48E3-4FD7-A814-E85373948569Q36901244-556D3AC9-B7CC-4083-824A-CB2E56679A3CQ36950527-282491C0-1724-4D46-8A42-896F65A1ACC7Q37008707-BC3EB5A6-BFBA-4049-B12D-BFE304FF57EAQ37023469-66CCF88F-4E9F-493B-9C34-F21BBE2B5C37Q37349169-3F061F7E-9B9C-4DBB-AEEC-22024E80CFA1Q37376820-542DF228-95ED-479E-AD7C-5DC38C744BEFQ37388219-ACACFE0D-89CF-4757-AB8C-AFFEC389983FQ37458313-2C6C833A-91AB-4D45-9FC8-04980FBE2B36Q37635564-9A952EF7-6E94-41EB-8C72-9B5456FFA1C1Q37660784-8C6911A9-75E4-474E-B1D9-5700D65D2C57
P2860
Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Updates of cost of illness and ...... ns of HIV prevention programs.
@en
Updates of cost of illness and ...... ns of HIV prevention programs.
@nl
type
label
Updates of cost of illness and ...... ns of HIV prevention programs.
@en
Updates of cost of illness and ...... ns of HIV prevention programs.
@nl
prefLabel
Updates of cost of illness and ...... ns of HIV prevention programs.
@en
Updates of cost of illness and ...... ns of HIV prevention programs.
@nl
P921
P1476
Updates of cost of illness and ...... ns of HIV prevention programs.
@en
P2093
Holtgrave DR
Pinkerton SD
P356
10.1097/00042560-199709010-00009
P407
P577
1997-09-01T00:00:00Z